Trump Order on Separate MMR Shots Coincides With 2,465 Measles Cases in 2026

The order mandates separate appointments for routine vaccines where feasible and directs states to review school requirements while again citing autism concerns despite extensive evidence. Combination MMR remains 97% effective after two doses per CDC surveillance data through 2025. Separate schedules increase missed doses by 12-18% in observational cohorts from states with prior policy experiments.

Large cohort studies in NEJM 2022 and JAMA 2024 involving over 2 million children found no causal MMR-autism link after adjusting for confounders. The policy lacks RCT support and echoes prior hesitancy patterns that dropped kindergarten MMR coverage below 92% in multiple states. Ebola vaccine deployment in DRC outbreaks shows timely immunization reduces transmission chains when logistics remain simple.

Rising susceptibility now allows measles to exploit gaps, with 2026 cases already surpassing prior annual peaks. Modeling from prior outbreaks indicates each 1% coverage drop adds 200-300 preventable infections annually in under-vaccinated clusters.

Next steps require tracking state-level requirement changes and appointment completion rates through 2027 to quantify delayed protection effects.